John P. Groetelaars
President and Chief Executive Officer
John P. Groetelaars joined Hill-Rom Holdings, Inc., as president and chief executive officer in May 2018. Previously, Mr. Groetelaars was executive vice president and president of Becton, Dickinson and Company’s (BD) Interventional Segment, where his responsibilities included global strategic, operational and commercial performance, and delivering the segment’s financial performance and innovation platform. Prior to the BD acquisition of C.R. Bard, Mr. Groetelaars was group president at Bard, which he had joined in 2008. He previously held positions of increasing responsibility with Boston Scientific Corporation, Guidant Corporation and Eli Lilly. Mr. Groetelaars earned his bachelor’s degree in Mechanical Engineering from Kettering University in Michigan, and an MBA from Columbia University in New York.
Senior Vice President, President International
Carlos Alonso was appointed senior vice president and president, International in April 2015. Before joining Hill-Rom, Mr. Alonso served as the president and CEO of the Esaote Group, a medical imaging leader based in Genova, Italy. Prior to the Esaote Group, Mr. Alonso served as the CEO of Esteve Pharmaceuticals based in Barcelona, Spain, and held various leadership roles of increasing responsibility with Baxter International Inc. over the course of 15 years, including serving as global president of the Renal Division. Mr. Alonso holds a master’s degree in chemical process automation from the Instituto Quimico de Sarriá in Barcelona, Spain, and a master’s degree in management from IESE – Universidad de Navarra, also in Barcelona, Spain.
Barbara W. Bodem
Senior Vice President, Chief Financial Officer
Barbara W. Bodem was appointed senior vice president and chief financial officer of Hill-Rom in December 2018. Ms. Bodem joined Hill-Rom from Mallinckrodt, where she served as senior vice president, Finance. Earlier in her career Ms. Bodem worked at Hospira as vice president, Global Commercial Finance, as well as at Eli Lilly and Company, where she held a variety of Finance roles in the U.S. and the U.K., including serving as CFO for Lilly Oncology. Ms. Bodem recently served as a member of the board of directors of Invacare Corporation. She earned her bachelor's of science in finance and MBA from Indiana University.
Senior Vice President, President Global Surgical Solutions
Francisco Canal was appointed senior vice president and president, Surgical Solutions in June 2017. Mr. Canal joined Hill-Rom in October 2015 as president, Hill-Rom Europe, and has played a key role in that region’s growth. Before joining Hill-Rom, Mr. Canal held several senior executive roles at Baxter, Gambro and, most recently, Smith and Nephew. He has lived and worked in Europe, the Middle East and Asia. He holds an MBA from IMD in Switzerland, a master’s degree in chemical engineering from Institut Quimic de Sarria in Barcelona and a master’s degree in industrial engineering from Universitat Ramon Llull in Barcelona.
Andreas G. Frank
Senior Vice President and President, Front Line Care
Andreas G. Frank was appointed senior vice president and president, Front Line Care, in December 2018. Mr. Frank joined Hill-Rom in 2011 as senior vice president, Corporate Development and Strategy, and most recently served in the additional role of chief transformation officer. Prior to joining Hill-Rom, he served as director of Corporate Development and vice president, Business Development, at Danaher Corporation. He previously worked in the Corporate Finance and Strategy practice at McKinsey & Company. Mr. Frank earned master’s degrees in business administration and economics from the Otto Beisheim School of Management in Germany and The University of Texas at Austin, Red McCombs School of Business, respectively.
Chief Information Officer
Anjana Harve joined Hill-Rom as chief information officer in October 2018. Ms. Harve served most recently as global head of Compliance Services and Information Management at Novartis, and previously as Americas CIO of its Alcon division. Prior to Novartis, Ms. Harve held leadership positions at Shire, where she was a division CIO, and CSL Behring, where she served as head of IT and global applications. Ms. Harve earned her MBA at the Wharton School of the University of Pennsylvania, and her bachelor's degree in computer science engineering from Bangalore University in India.
Senior Vice President, President Patient Support Systems
Paul (PJ) Johnson was appointed senior vice president and president, Patient Support Systems (PSS) in November 2016. Mr. Johnson joined Hill-Rom in 2013 as a senior sales leader for the U.S. PSS business. Prior to joining Hill-Rom, he worked for Life Technologies, where he was most recently President of its Americas region. Before his tenure at Life Technologies, Mr. Johnson spent 18 years with General Electric in a series of increasingly senior sales executive roles, culminating in his position as general manager, Sales and Marketing, in GE’s Clinical Information Systems business. Mr. Johnson earned his bachelor’s in mechanical engineering from Worcester Polytechnic Institute, and an MBA from the University of Wisconsin.
Mary Kay Ladone
Senior Vice President, Corporate Development, Strategy and Investor Relations
Mary Kay Ladone was appointed senior vice president, Corporate Development, Strategy and Investor Relations, in December 2018. Ms. Ladone has served as vice president, Investor Relations, since joining Hill-Rom in July 2016. Previously, she served as senior vice president, Investor Relations, of Baxalta Incorporated. Prior to that, she served in a variety of finance, business development and investor relations roles for Baxter International. Ms. Ladone holds a degree in finance and economics from the University of Notre Dame, and is a member of the Edward Elmhurst Hospital System Board of Trustees.
Senior Vice President, Chief Technology Officer
Brian Lawrence was appointed senior vice president, Innovation and Technology, and chief technology officer in October 2017. Mr. Lawrence joined Hill-Rom in December 2010 as senior vice president and chief technology officer. Prior to Hill-Rom, he served as chief technology officer for GE Healthcare’s Life Support Solutions business and held other leadership and innovation positions in GE's Global Research Center. Before GE, Mr. Lawrence was president and CEO of Extend Optical Systems Corporation and senior vice president of Research and Development and chief technology officer for Molecular OptoElectronics Corporation. Mr. Lawrence holds undergraduate and graduate degrees from the Massachusetts Institute of Technology (MIT) and a Ph.D. from the Center for Research and Education in Optics and Lasers (CREOL) at the University of Central Florida.
Senior Vice President, Operations
Tim Lawrence was appointed senior vice president, Operations in September 2017. Prior to joining Hill-Rom, Mr. Lawrence spent 15 years in various positions with increasing responsibility at Baxter International Inc., including most recently as corporate vice president for Operations where he oversaw 60 manufacturing plants spanning 30 countries. Earlier in his career, he served as a general manager for Precision Components International, part of The Wertheimer Group, and for Pratt and Whitney. Prior to his business career, Mr. Lawrence was a commissioned infantry officer in the U.S. Army. He holds a bachelor's degree from the United States Military Academy at West Point and a master's degree in management from Purdue University.
Senior Vice President, Chief Marketing Officer
Richard Marritt was appointed chief marketing officer of Hill-Rom in October 2018; he served previously as chief marketing officer of Hill-Rom subsidiary Welch Allyn for two years, a role in which he was responsible for creating and executing a commercial marketing strategy to drive growth and access to Welch Allyn’s products and services throughout the world. Prior to joining Hill-Rom, Mr. Marritt held various positions over 17 years with Baxter International, most recently serving as the global franchise head of its Acute, Renal Therapy Services & Software businesses. Formerly, he served as region head for the U.S. & Canada, general manager for Baxter’s U.S. Renal business, and vice president of the Bioscience division for Latin America and Canada. Mr. Marritt earned his bachelor’s degree in Business Administration from Brock University and his masters of science degree from the University of Guelph in Guelph, Ontario.
Senior Vice President, Chief Human Resources Officer
Kenneth (Ken) Meyers was appointed senior vice president and chief human resources officer in September 2015. Prior to joining Hill-Rom, Mr. Meyers held the same role at Hospira, Inc. from 2008 until its acquisition in 2015 by Pfizer, Inc. For several years prior to his tenure at Hospira, Mr. Meyers was a partner at Mercer / Oliver Wyman Consulting, specializing in leadership development of general managers and HR professionals. Prior to Mercer / Oliver Wyman, Mr. Meyers served as senior vice president, Human Resources, for Starbucks Coffee International. Mr. Meyers also held human resources positions of increasing responsibility during his career at The Gymboree Corporation, Walt Disney Imagineering and United Technologies. He has lived and worked in the U.S., England, France and South Africa. Mr. Meyers serves on the board of directors of Syneos Health (NASDAQ: SYNH), the only fully integrated end-to-end clinical and commercial solution organization, where he chairs the Compensation Committee and serves on the Nominating & Governance Committee. Mr. Meyers holds a bachelor’s degree in International Business and Human Resource Management from the University of Pennsylvania’s Wharton School and an MBA from the Harvard Business School.
Michael J. Murphy
Senior Vice President, Quality Assurance and Regulatory Affairs
Michael J. Murphy was appointed senior vice president, Quality Assurance and Regulatory Affairs (QARA) in July 2012. Mr. Murphy joined Hill-Rom as vice president of QARA in May 2011. Prior to joining Hill-Rom, he was with Baxter International Inc., where he spent three years in Switzerland as vice president of Quality for Europe, Middle East, & Africa before being promoted to vice president II, Corporate Quality at Baxter headquarters outside Chicago. Mr. Murphy’s previous experience also included senior-level Quality & Regulatory positions at Boston Scientific and a company formerly owned by J&J, Harmac Medical. Mr. Murphy served in the U.S. Air Force active duty and reserve and holds a bachelor’s degree in Industrial Technology Management with concentrations in Biomedical Engineering and Management from The State University of New York, Buffalo.
Deborah M. Rasin
Senior Vice President, Chief Legal Officer and Secretary
Deborah M. Rasin was appointed senior vice president, chief legal officer and secretary in January 2016. Before joining Hill-Rom, Ms. Rasin served as vice president, secretary and general counsel at DENTSPLY International Inc., the NASDAQ-listed leading manufacturer and distributor of dental and other consumable healthcare products. Prior to DENTSPLY, Ms. Rasin served as vice president of Legal, general counsel and secretary of Samsonite Corporation, and subsequently was a partner in a private law practice in London, England. Prior to joining Samsonite, Ms. Rasin spent ten years as a senior commercial and corporate attorney for General Motors Corporation. In addition to residing in the United States and the United Kingdom, she has lived and worked in Hong Kong, Switzerland and Israel. Ms. Rasin holds a bachelor’s degree from Harvard College and juris doctor from Harvard Law School.
Chief Compliance Officer
Ilana Shulman was appointed chief compliance officer in November 2014. Prior to joining Hill-Rom, Ms. Shulman worked at Astellas U.S., where she was responsible for all legal and compliance issues for Latin America as well as the anti-bribery and anti-corruption program. Prior to Astellas U.S., she spent 12 years at Pfizer in a variety of roles in Legal, Compliance and Public Affairs, including supporting the Worldwide Public Affairs and Policy groups and the Latin American, European and Japan/Asia regions. Before joining Pfizer, Ms. Shulman worked at Sullivan & Cromwell, where she specialized in securities transactions with Latin American and Spanish clients. Ms. Shulman also clerked for Chief Judge Gregory Carman on the U.S. Court of International Trade. Ms. Shulman holds a bachelor’s degree in Government and Spanish from Dartmouth College, a juris doctor from Columbia Law School and a master’s degree in International Affairs from Columbia School of International and Public Affairs.